The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| OM | +33.52% | -98.28% | -55.63% | -99% |
| S&P | +17.53% | +93.66% | +14.13% | +100% |
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Outset Medical managed notable improvements in operational efficiency and gross margins in Q4.
Outset Medical reported mixed results, with higher revenue but a wider loss than expected.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $31.42M | 14.7% |
| Gross Profit | $11.87M | 21.3% |
| Gross Margin | 37.77% | 2.1% |
| Market Cap | $340.45M | 71.0% |
| Market Cap / Employee | $0.71M | 0.0% |
| Employees | 480 | 0.0% |
| Net Income | -$18.54M | 46.2% |
| EBITDA | -$15.71M | 46.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $39.56M | 4.5% |
| Accounts Receivable | $34.89M | 2.3% |
| Inventory | 52.2 | -15.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $96.52M | -51.9% |
| Short Term Debt | $1.91M | 12.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -32.45% | 16.6% |
| Return On Invested Capital | -47.13% | -28.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$5.12M | 84.7% |
| Operating Free Cash Flow | -$4.82M | 85.5% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.74 | 2.19 | 1.46 | 2.05 | -3.99% |
| Price to Sales | 0.30 | 0.51 | 0.68 | 2.86 | 66.53% |
| Price to Tangible Book Value | 11.16 | 18.29 | 1.46 | 2.05 | -93.60% |
| Enterprise Value to EBITDA | -2.70 | -5.34 | 0.61 | -16.49 | 133.11% |
| Return on Equity | -141.0% | -171.0% | -86.5% | -87.7% | -30.70% |
| Total Debt | $202.08M | $201.86M | $98.17M | $98.43M | -51.35% |
It's Motley Fool Money's annual Thanksgiving financial meal. We're serving up humble pie, talking about the topics we're skipping this year at the dinner table, and answering questions you've sent our way.
Plus, a look at distraction.
Discover how Outset Medical is making dialysis easier and cheaper.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
